BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Talks.cam//talks.cam.ac.uk//
X-WR-CALNAME:Talks.cam
BEGIN:VEVENT
SUMMARY:Structure Based Drug Design - Jon Read\, Judit Debreczeni and Andr
 ew Doré
DTSTART:20141211T163000Z
DTEND:20141211T180000Z
UID:TALK56530@talks.cam.ac.uk
CONTACT:Claus Bendtsen
DESCRIPTION:The first AstraZeneca hosted seminar at our Darwin building on
  the Cambridge Science Park. The seminar will consist of three presentatio
 ns:\n\n1) A dual fragment/biochemical screening approach to targeting InhA
 \, a Tuberculosis target by Jon Read from AstraZeneca\n\n2) Structure-ba
 sed design of potent and selective inhibitors of the metabolic kinase PFK
 FB3 by Judit Debreczeni from AstraZeneca\n\n3) Crystal Structure of a Cla
 ss C GPCR – metabotropic glutamate receptor 5 (mGluR5) by Andrew Doré
  from Heptares\n\nAbstracts & registration @ https://eventbrite.co.uk/eve
 nt/14503848401 \n
LOCATION:Building 310 on the Cambridge Science Park
END:VEVENT
END:VCALENDAR